DNA Repair Defects Are Strong Targets for Therapeutic Development in Prostate Cancer
June 11th 2018The use of PARP inhibitors in patients with a variety of tumor types is backed by a growing body of research, and there is now strong justification for clinical trials of these agents in patients with prostate cancer.
Urology Practice Keeps Up With Technology Through Physician-Owned Business Model
June 1st 2018Greater Boston Urology strives to offer comprehensive urologic care that includes up-and-coming diagnostics and treatments, such as the Prostate Health Index blood test and high intensity–focused ultrasound.